Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.54
(-2.84%)
CNY 7.54
(-2.84%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 120.42 Million CNY | -30.06% |
| 2022 | 176.9 Million CNY | -8.66% |
| 2021 | 193.67 Million CNY | 59.58% |
| 2020 | 121.36 Million CNY | -6.12% |
| 2019 | 129.28 Million CNY | -9.05% |
| 2018 | 142.14 Million CNY | -39.36% |
| 2017 | 234.42 Million CNY | -9.6% |
| 2016 | 259.31 Million CNY | 6.69% |
| 2015 | 243.04 Million CNY | 8.76% |
| 2014 | 223.47 Million CNY | -9.79% |
| 2013 | 247.71 Million CNY | 2.46% |
| 2012 | 241.77 Million CNY | 21.73% |
| 2011 | 198.61 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 30.75 Million CNY | 24.22% |
| 2024 Q3 | 33.37 Million CNY | 65.54% |
| 2024 Q2 | 20.65 Million CNY | -32.82% |
| 2023 Q1 | 42.93 Million CNY | 341.19% |
| 2023 FY | 123.71 Million CNY | -30.06% |
| 2023 Q2 | 33.03 Million CNY | -23.07% |
| 2023 Q4 | 24.75 Million CNY | -22.63% |
| 2023 Q3 | 31.99 Million CNY | -3.13% |
| 2022 Q3 | 60.31 Million CNY | 3.92% |
| 2022 FY | 176.9 Million CNY | -8.66% |
| 2022 Q4 | 9.73 Million CNY | -83.86% |
| 2022 Q1 | 48.81 Million CNY | -15.04% |
| 2022 Q2 | 58.04 Million CNY | 18.92% |
| 2021 FY | 193.67 Million CNY | 59.58% |
| 2021 Q1 | 55.78 Million CNY | 99.08% |
| 2021 Q2 | 37.47 Million CNY | -32.83% |
| 2021 Q3 | 42.96 Million CNY | 14.65% |
| 2021 Q4 | 57.44 Million CNY | 33.72% |
| 2020 Q4 | 28.02 Million CNY | -25.24% |
| 2020 Q1 | 25.2 Million CNY | -28.54% |
| 2020 Q3 | 37.48 Million CNY | 22.3% |
| 2020 Q2 | 30.64 Million CNY | 21.58% |
| 2020 FY | 121.36 Million CNY | -6.12% |
| 2019 Q1 | 31.56 Million CNY | 79.0% |
| 2019 FY | 129.28 Million CNY | -9.05% |
| 2019 Q2 | 32.68 Million CNY | 3.56% |
| 2019 Q4 | 35.27 Million CNY | 18.57% |
| 2019 Q3 | 29.75 Million CNY | -8.99% |
| 2018 Q1 | 39.1 Million CNY | -13.43% |
| 2018 FY | 142.14 Million CNY | -39.36% |
| 2018 Q4 | 17.63 Million CNY | -65.72% |
| 2018 Q3 | 51.44 Million CNY | 51.44% |
| 2018 Q2 | 33.96 Million CNY | -13.13% |
| 2017 Q1 | 57.71 Million CNY | -12.11% |
| 2017 FY | 234.42 Million CNY | -9.6% |
| 2017 Q4 | 45.17 Million CNY | -36.49% |
| 2017 Q3 | 71.12 Million CNY | 17.72% |
| 2017 Q2 | 60.41 Million CNY | 4.69% |
| 2016 Q2 | 60.99 Million CNY | 1.73% |
| 2016 FY | 259.31 Million CNY | 6.69% |
| 2016 Q3 | 72.69 Million CNY | 19.19% |
| 2016 Q1 | 59.95 Million CNY | -0.82% |
| 2016 Q4 | 65.66 Million CNY | -9.68% |
| 2015 Q1 | 56.32 Million CNY | 37.24% |
| 2015 FY | 243.04 Million CNY | 8.76% |
| 2015 Q4 | 60.45 Million CNY | -8.45% |
| 2015 Q3 | 66.03 Million CNY | 9.63% |
| 2015 Q2 | 60.23 Million CNY | 6.93% |
| 2014 FY | 223.47 Million CNY | -9.79% |
| 2014 Q3 | 55.44 Million CNY | -13.28% |
| 2014 Q1 | 63.03 Million CNY | 0.0% |
| 2014 Q2 | 63.94 Million CNY | 1.43% |
| 2014 Q4 | 41.04 Million CNY | -25.98% |
| 2013 FY | 247.71 Million CNY | 2.46% |
| 2012 FY | 241.77 Million CNY | 21.73% |
| 2011 FY | 198.61 Million CNY | 0.0% |